Improving Digit-Symbol Scores Across Cannabis Conditions Were Consistent With Practice

When digit-symbol scores improved in every treatment condition, improvement alone did not demonstrate a beneficial cannabis effect. The review identified practice as a plausible explanation for that shared trajectory.

The comparison included placebo

In a spinal-cord-related neuropathic-pain trial, repeated Digit Symbol Test scores improved over time across conditions. The review reports no significant dose-effect differences on that measure and describes the common improvement as consistent with practice effects.

Within-condition gains are not a treatment advantage

A participant can become more familiar with a task during repeated testing. If the control condition improves as well, a higher later score is not independently evidence of pharmacological cognitive enhancement. The relevant treatment inference needs a comparison accounting for that shared change.

Practice was an interpretation rather than a uniquely proven cause

The pattern supports the explanation but does not isolate every contributor, such as changing symptoms or other session effects. It also does not invalidate different tasks that did show THC-related differences in the same trial. The balanced account preserves a task-specific null drug comparison and the improvement common to conditions. Such information helps prevent a repeated-testing gain from being advertised as a cannabis benefit or used to erase a separate observed deficit.

Related analysis: the review’s broader findings and limitations.

Research cited

This analysis draws on the supplied review: Eadie and colleagues (2021). Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review. Frontiers in Psychiatry.

Study discussed in that review: DOI 10.1016/j.jpain.2016.05.010.